Page last updated: 2024-08-23

paroxetine and Body Weight

paroxetine has been researched along with Body Weight in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.56)18.7374
1990's10 (25.64)18.2507
2000's19 (48.72)29.6817
2010's7 (17.95)24.3611
2020's2 (5.13)2.80

Authors

AuthorsStudies
Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S1
Ogunro, OB; Yakubu, MT1
Liebl, C; Müller, MB; Scharf, SH; Schmidt, MV; Sterlemann, V1
Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ1
Pines, A1
Bachmann, G1
Breuer, ME; Campbell, U; Chan, JS; Groenink, L; Hanania, T; Korte, SM; Olivier, B; Oosting, RS; Schreiber, R; Snoeren, EM; Waldinger, M1
Terao, T1
Gutierrez, AM; Mohammadi, M; Weber, M1
Dadić-Hero, E; Kabalin, M; Medved, P; Pernar, M; Ruzić, K1
Lau, BW; Lee, TM; Leung, N; Li, SY; So, KF; Tang, SW; Wang, H; Wang, NL; Yau, SY1
Graham, DL; Morford, LR; Skelton, MR; Vorhees, CV; Williams, MT1
Bermudez, I; Franklin, M; Gaburro, S; Murck, H; Singewald, N1
Barbagli, B; Boissard, R; Fort, P; Gervasoni, D; Henninot, V; Luppi, PH; Panconi, E1
Bush, VL; Fone, KC; Marsden, CA; Middlemiss, DN1
Sari, Y; Xu, Y; Zhou, FC1
Aubel, B; Bourgoin, S; Farré, A; Hamon, M; Kayser, V; Mauborgne, A1
Bitter, I; Demitrack, MA; Detke, MJ; Mallinckrodt, CH; McNamara, RK; Wiltse, CG1
Nalepa, I; Roman, A1
Cools, AR; de Jong, TR; Olivier, B; Pattij, T; Snaphaan, LJ; Veening, JG; Waldinger, MD1
Bies, RR; Feng, Y; Ferrell, RE; Kimak, MA; Pollock, BG; Reynolds, CF1
Andreatini, R; Casarotto, PC1
Nagata, T; Nakayama, K; Ono, K1
Rowland, NE1
Barnes, GA; McCook, EC; Seidler, FJ; Slotkin, TA1
Hayashi-Kuwabara, Y; Ikeda, Y; Izumi, J; Kiuchi, Y; Oguchi, K; Tanaka, Y; Washizuka, M; Yoshinaga, K1
Huether, G; Rüther, E; Schmidt, S; Wiltfang, J; Zhou, D1
Cozzi, NV; Frescas, S; Huang, X; Marona-Lewicka, D; Nichols, DE1
Bissette, G; Fumagalli, F; McCook, EC; Miller, DB; Seidler, FJ; Slotkin, TA; Zhang, J1
Begg, EJ; Sainsbury, R; Wilkinson, TJ; Winter, AC1
Bielajew, C; Konkle, AT1
Christensen, HD; Coleman, FH; Gonzalez, CL; Rayburn, WF1
Connor, TJ; Kelly, JP; Leonard, BE; Nolan, Y; Shen, Y1
Blanchard, DC; Blanchard, RJ; Magariños, AM; McEwen, BS; McKittrick, CR; Sakai, RR1
Haack, M; Hinze-Selch, D; Kraus, T; Kühn, M; Pollmächer, T; Schuld, A; Uhr, M1
Begley, A; Mazumdar, S; Mulsant, B; Pollock, BG; Stack, J; Weber, E1
Chambers, PL; Kelly, JP; Leonard, BE; Ryan, PM1
Huot, RL; Meaney, MJ; Plotsky, PM; Thrivikraman, KV1
Baldwin, JA; Davidson, EJ; Pritchard, AL; Ridings, JE1

Trials

5 trial(s) available for paroxetine and Body Weight

ArticleYear
Chronic social stress during adolescence: interplay of paroxetine treatment and ageing.
    Neuropharmacology, 2013, Volume: 72

    Topics: Adrenal Glands; Aging; Animals; Arginine Vasopressin; Body Weight; Chronic Disease; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Longitudinal Studies; Male; Mice; Paroxetine; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Social Isolation; Stress, Psychological; Thymus Gland

2013
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:10

    Topics: Adult; Aged; Body Mass Index; Body Weight; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Single-Blind Method

2014
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2004, Volume: 14, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Body Weight; Cardiovascular Diseases; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Electrocardiography; Female; Hemodynamics; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Thiophenes

2004
Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.
    British journal of clinical pharmacology, 2006, Volume: 61, Issue:5

    Topics: Age Factors; Aged; Body Weight; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Genotype; Humans; Male; Nonlinear Dynamics; Paroxetine; Polymerase Chain Reaction; Racial Groups; Selective Serotonin Reuptake Inhibitors; Sex Factors

2006
Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2000,Summer, Volume: 8, Issue:3

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Body Weight; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Weight Gain; Weight Loss

2000

Other Studies

34 other study(ies) available for paroxetine and Body Weight

ArticleYear
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
    BMC medicine, 2022, 07-26, Volume: 20, Issue:1

    Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain

2022
Fadogia agrestis (Schweinf. Ex Hiern) Stem Extract Restores Selected Biomolecules of Erectile Dysfunction in the Testicular and Penile Tissues of Paroxetine-Treated Wistar Rats.
    Reproductive sciences (Thousand Oaks, Calif.), 2023, Volume: 30, Issue:2

    Topics: Animals; Arginase; Body Weight; Catalase; Erectile Dysfunction; Humans; Hydrogen Peroxide; Male; Paroxetine; Plant Extracts; Rats; Rats, Wistar; Sildenafil Citrate; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances

2023
Safety of low-dose paroxetine.
    Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:3

    Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological

2014
Another option for menopausal vasomotor symptoms without negative impact on weight and sexual function.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:10

    Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological

2014
The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:12

    Topics: Animals; Antidepressive Agents; Aza Compounds; Behavior, Animal; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Ejaculation; Exploratory Behavior; Male; Olfactory Bulb; Paroxetine; Rats; Rats, Sprague-Dawley; Reaction Time; Statistics, Nonparametric

2008
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
    Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis

2008
The risks and benefits of switching antipsychotics: a case study approach.
    Perspectives in psychiatric care, 2009, Volume: 45, Issue:1

    Topics: Antipsychotic Agents; Benzodiazepines; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertriglyceridemia; Long-Term Care; Male; Middle Aged; Olanzapine; Paroxetine; Psychotic Disorders; Risk Assessment; Schizophrenia; Thioridazine

2009
Olanzapine treatment in anorexia nervosa: case report.
    Psychiatria Danubina, 2009, Volume: 21, Issue:1

    Topics: Adolescent; Ambulatory Care; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Body Weight; Combined Modality Therapy; Defense Mechanisms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; MMPI; Olanzapine; Paroxetine; Psychotherapy

2009
Roles of paroxetine and corticosterone on adult mammalian ciliary body cell proliferation.
    Chinese medical journal, 2010, May-20, Volume: 123, Issue:10

    Topics: Adrenal Glands; Animals; Body Weight; Cell Proliferation; Ciliary Body; Corticosterone; Immunohistochemistry; In Vitro Techniques; Male; Organ Size; Paroxetine; Rats; Rats, Sprague-Dawley

2010
Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.
    Behavioral and brain functions : BBF, 2011, Oct-05, Volume: 7

    Topics: Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Body Weight; Brain; Corticosterone; Critical Period, Psychological; Dose-Response Relationship, Drug; Escape Reaction; Exploratory Behavior; Fluoxetine; Immobility Response, Tonic; Longitudinal Studies; Male; Maze Learning; Paroxetine; Rats; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Sensory Gating

2011
Sub-chronic dietary tryptophan depletion--an animal model of depression with improved face and good construct validity.
    Journal of psychiatric research, 2012, Volume: 46, Issue:2

    Topics: Aldosterone; Analysis of Variance; Animals; Body Weight; Brain; Calcium-Binding Proteins; Catecholamines; Chromatography, High Pressure Liquid; Corticosterone; Depression; Diet; Disease Models, Animal; DNA-Binding Proteins; Kynurenic Acid; Kynurenine; Male; Nerve Tissue Proteins; Nucleobindins; Paroxetine; Protein Binding; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Swimming; Time Factors; Tritium; Tryptophan

2012
Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 73, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclopropanes; Imipramine; Male; Milnacipran; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Stages; Sleep, REM; Wakefulness

2002
Implantation of a slow release corticosterone pellet induces long-term alterations in serotonergic neurochemistry in the rat brain.
    Journal of neuroendocrinology, 2003, Volume: 15, Issue:6

    Topics: Adrenal Glands; Animals; Body Weight; Carrier Proteins; Corticosterone; Depression; Disease Models, Animal; Drug Implants; Frontal Lobe; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organ Size; Paroxetine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time

2003
Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development.
    Brain research. Developmental brain research, 2004, Jun-21, Volume: 150, Issue:2

    Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Carrier Proteins; Female; Immunohistochemistry; Isoenzymes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neural Pathways; Paroxetine; Phospholipase C beta; Pregnancy; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Somatosensory Cortex; Thalamus; Type C Phospholipases; Vibrissae

2004
Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies.
    Pain, 2004, Volume: 110, Issue:1-2

    Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drinking; Drug Interactions; Glycemic Index; Hyperalgesia; Idazoxan; Infusion Pumps, Implantable; Male; Pain Measurement; Pain Threshold; Paroxetine; Pyrazoles; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Streptozocin; Time Factors

2004
Effect of repeated administration of paroxetine and electroconvulsive shock on the proliferative response of lymphocytes and the synthesis of nitric oxide by macrophages in rats.
    The journal of ECT, 2005, Volume: 21, Issue:2

    Topics: Animals; Antidepressive Agents, Second-Generation; Body Weight; Cell Division; Drug Administration Schedule; Electroshock; Lipopolysaccharides; Lymphocytes; Macrophages, Peritoneal; Male; Nitric Oxide; Organ Size; Paroxetine; Rats; Rats, Wistar; Spleen

2005
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Radiation; Drug Interactions; Fluvoxamine; Inhibition, Psychological; Male; Maze Learning; Paroxetine; Rats; Rats, Wistar; Reaction Time; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Sexual Behavior, Animal; Swimming

2006
Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2007, Volume: 17, Issue:11

    Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Depression; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Food Preferences; Glucocorticoids; Male; Paroxetine; Rats; Rats, Wistar; Stress, Psychological; Time Factors

2007
Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder.
    Psychiatry and clinical neurosciences, 2007, Volume: 61, Issue:4

    Topics: Anorexia Nervosa; Antidepressive Agents, Second-Generation; Benzodiazepines; Body Weight; Bulimia; Chronic Disease; Female; Hospitalization; Humans; Mianserin; Middle Aged; Olanzapine; Paroxetine; Schizotypal Personality Disorder; Selective Serotonin Reuptake Inhibitors

2007
Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: body weight and brain serotonin changes.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 49, Issue:2

    Topics: Animals; Blood Glucose; Body Weight; Brain Chemistry; Corticosterone; Dietary Fats; Female; Fenfluramine; Mice; Mice, Inbred C57BL; Mice, Obese; Norfenfluramine; Obesity; Paroxetine; Serotonin

1994
Programming of brainstem serotonin transporter development by prenatal glucocorticoids.
    Brain research. Developmental brain research, 1996, May-31, Volume: 93, Issue:1-2

    Topics: Animals; Binding Sites; Body Weight; Brain Stem; Carrier Proteins; Cell Differentiation; Cell Division; Dexamethasone; Female; Glucocorticoids; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tritium

1996
Protective effect of citalopram against the attenuation of the alpha 1-potentiation of cAMP formation in Fischer 344 strain rats.
    Behavioural brain research, 1997, Volume: 83, Issue:1-2

    Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Citalopram; Cyclic AMP; Depression; Imipramine; Male; Motor Activity; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Stress, Psychological

1997
Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex.
    Biological psychiatry, 1997, Jun-15, Volume: 41, Issue:12

    Topics: Aging; Animals; Body Weight; Carrier Proteins; Down-Regulation; Frontal Lobe; Male; Membrane Glycoproteins; Membrane Transport Proteins; Membranes; Mesencephalon; Nerve Tissue Proteins; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Starvation

1997
Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:3

    Topics: Animals; Appetite Depressants; Body Weight; Brain Chemistry; Discrimination, Psychological; Fenfluramine; In Vitro Techniques; Indans; Male; Nervous System Diseases; Neurotransmitter Uptake Inhibitors; Norfenfluramine; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Serotonin; Synaptosomes

1998
Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1

    Topics: Adenylyl Cyclases; Aging; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Behavior, Animal; Body Weight; Brain; Carrier Proteins; Depressive Disorder; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Olfactory Bulb; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Reflex, Startle; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins

1999
Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people.
    British journal of clinical pharmacology, 1999, Volume: 47, Issue:2

    Topics: Aged; Antidepressive Agents, Second-Generation; Body Weight; Female; Fluoxetine; Humans; Hyponatremia; Male; Paroxetine; Retrospective Studies; Risk Factors; Time Factors

1999
Feeding and reward interactions from chronic paroxetine treatment.
    Pharmacology, biochemistry, and behavior, 1999, Volume: 63, Issue:3

    Topics: Animals; Body Weight; Conditioning, Operant; Dose-Response Relationship, Drug; Electrodes, Implanted; Feeding Behavior; Male; Medial Forebrain Bundle; Paroxetine; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reward; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques

1999
Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil)
    American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:5 Pt 1

    Topics: Aggression; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Body Weight; Depression; Exploratory Behavior; Female; Homing Behavior; Litter Size; Male; Maternal Exposure; Mice; Motor Activity; Paroxetine; Play and Playthings; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sleep; Time Factors; Vocalization, Animal

1999
Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.
    Life sciences, 1999, Volume: 65, Issue:17

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclohexanols; Desipramine; Drinking Behavior; Eating; Endotoxins; Escherichia coli; Interleukin-10; Lipopolysaccharides; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride

1999
Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites.
    Synapse (New York, N.Y.), 2000, Volume: 36, Issue:2

    Topics: Animals; Binding Sites; Body Weight; Carrier Proteins; Cell Size; Chronic Disease; Corticosterone; Dendrites; Female; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Pyramidal Cells; Radioligand Assay; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological

2000
Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:1

    Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Female; Humans; Leptin; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nortriptyline; Paroxetine; Receptors, Leptin; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha

2000
The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat.
    Pharmacology & toxicology, 2001, Volume: 88, Issue:2

    Topics: Animal Testing Alternatives; Animals; Behavior, Animal; Body Temperature; Body Weight; Dose-Response Relationship, Drug; Drinking; Eating; Erythrocytes; Female; Hematocrit; Hemoglobins; Liver; Models, Animal; Motor Activity; Organ Size; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors

2001
Development of adult ethanol preference and anxiety as a consequence of neonatal maternal separation in Long Evans rats and reversal with antidepressant treatment.
    Psychopharmacology, 2001, Volume: 158, Issue:4

    Topics: Adrenocorticotropic Hormone; Alcohol Drinking; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Anxiety; Body Weight; Corticosterone; Female; Male; Maternal Deprivation; Paroxetine; Pituitary-Adrenal System; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Stress, Psychological

2001
The reproductive toxicology of paroxetine.
    Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350

    Topics: Abnormalities, Drug-Induced; Animals; Antidepressive Agents; Body Weight; Dose-Response Relationship, Drug; Female; Litter Size; Paroxetine; Piperidines; Pregnancy; Pregnancy, Animal; Rabbits; Rats; Serotonin Antagonists

1989